The Keio Journal of Medicine

Abstract
Transcriptional pro?ling of the scleroderma ?broblast reveals a potential role for connective tissue growth factor (CTGF) in pathological ?brosis
Andrew Leask

The cause of ?brotic disease is unknown. We have undertaken transcriptional pro?ling of dermal ?broblasts cultured from patients with the ?brotic disease scleroderma (systemic sclerosis, SSc) to identify genes overexpressed in ?brosis and have explored their contribution to the ?brotic phenotype. Connective tissue growth factor (CTGF, CCN2), a member of the CCN family of proteins, is overexpressed in SSc ?broblasts. In adult skin, CTGF is not normally expressed in dermal ?broblasts. However, CTGF is induced during the wound healing response and is constitutively overexpressed by ?broblasts present in ?brotic lesions. The overexpression of CTGF present in ?brotic lesions contributes to the phenotype of scleroderma in that CTGF promotes matrix deposition, and ?broblast adhesion and proliferation. In animal models, whereas either TGFb or CTGF alone produce only a transient ?brotic response, CTGF and TGFb act together to promote sustained ?brosis. Thus the constitutive overexpression of CTGF by ?broblasts present in ?brotic lesions would be expected to directly contribute to chronic, persistent ?brosis. (Keio J Med 53 (2): 74?77, June 2004)